Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension

AIMS: Sinus tachycardia potentially leads to a deterioration of cardiac function in critically ill infants. The ultrashort‐acting beta‐blocker landiolol hydrochloride is a new pharmacological option for a selective heart rate (HR) control in patients with sinus tachycardia and heart failure. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroeder, Lukas, Monno, Paulina, Unger, Martin, Ackerl, Jakob, Shatilova, Olga, Schmitt, Joachim, Dresbach, Till, Mueller, Andreas, Kipfmueller, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871696/
https://www.ncbi.nlm.nih.gov/pubmed/36256500
http://dx.doi.org/10.1002/ehf2.14202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871696/
https://www.ncbi.nlm.nih.gov/pubmed/36256500
http://dx.doi.org/10.1002/ehf2.14202

Ejemplares similares